Causal AI analysis of MPN and neurodegenerative disease data

PharmaEssentia USA, announcing abstracts for the MPN Congress and ASH, said the program included an AI-based discovery analysis and listed a presentation described as a causal-AI dissection of RNA-seq data sets that pinpoints connections between myeloproliferative neoplasms and neurodegenerative diseases.